The blood-brain barrier and the neurovascular unit in subarachnoid hemorrhage: molecular events and potential treatments

Solár P, Zamani A, Lakatosová K, Joukal M.

Fluids Barriers CNS. 2022 Apr 11;19(1):29. doi:10.1186/s12987-022-00312-4. PMID: 35410231.


14 Apr 2022

No description

The response of the blood-brain barrier (BBB) following a stroke, including subarachnoid hemorrhage (SAH), has been studied extensively. The main components of this reaction are endothelial cells, pericytes, and astrocytes that affect microglia, neurons, and vascular smooth muscle cells. SAH induces alterations in individual BBB cells, leading to brain homeostasis disruption. Recent experiments have uncovered many pathophysiological cascades affecting the BBB following SAH. Targeting some of these pathways is important for restoring brain function following SAH. BBB injury occurs immediately after SAH and has long-lasting consequences, but most changes in the pathophysiological cascades occur in the first few days following SAH. These changes determine the development of early brain injury as well as delayed cerebral ischemia. SAH-induced neuroprotection also plays an important role and weakens the negative impact of SAH. Supporting some of these beneficial cascades while attenuating the major pathophysiological pathways might be decisive in inhibiting the negative impact of bleeding in the subarachnoid space. In this review, we attempt a comprehensive overview of the current knowledge on the molecular and cellular changes in the BBB following SAH and their possible modulation by various drugs and substances.

Keywords: Blood–brain barrier; Neuroinflammation; Neuronal injury; Neurovascular unit; Subarachnoid hemorrhage; Subarachnoid hemorrhage treatment.

More articles

All articles

You are running an old browser version. We recommend updating your browser to its latest version.

More info